Easterly Government Props Azioni (NYSE: DEA)

Ultime notizie per Easterly Government Props (NYSE:DEA) Azioni

EASTERLY GOVERNMENT PROPERTI

Easterly Government Props

Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.

Hand,Choosing,Wooden,House,Model,,Mortgage,And,Real,Estate,Property

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

Tre società del mattone mostrano segnali tecnici promettenti. In arrivo un&#39;inversione di rotta per gli investitori più attenti?

3 titoli del settore immobiliare che potrebbero esplodere ad aprile

Dividend,Growth,And,Profits,With,Finger,Pointing,On,The,Graph.

Dividends

Price Target

Analyst Ratings

RBC Capital e Truist Securities individuano opportunità nel settore immobiliare con rendimenti potenziali a due cifre.

Rendimento da dividendo fino all&#39;11%! 3 azioni consigliate dai migliori analisti

Dividend Yield

Le valutazioni aggiornate degli analisti rivelano opportunità e rischi nel settore REIT: ecco tre titoli per un flusso di cassa costante.

3 titoli immobiliari ad alto rendimento sotto la lente degli esperti

Easterly Government Properties, Inc. Common Stock

Easterly Government Properties Inc

DEAPcoin

DEALERADVANCE INC NEW by DealerAdvance, Inc.

DealerAdvance Inc

DEAR CASHMERE HOLDING CO by Dear Cashmere Holding Co.

Dear Cashmere Holding Co

<p>RBC Capital  analyst Michael Carroll   maintains Easterly Government Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>) with a Underperform and lowers the price target from $27.5 to $22.</p>


RBC Capital Maintains Underperform on Easterly Government Props, Lowers Price Target to $22

<p>From Texas&#8217; escalating war on hemp to EU-certified inhalers and Argentina&#8217;s full-scale overhaul of its medical cannabis program, this week offered no shortage of headlines that could shape the future of the cannabis industry across borders and sectors.</p>
<p>Let&#8217;s dig in. </p>
<h3 class="wp-block-heading">Policy &amp; Legal</h3>
<p><strong>Texas House Passes Hemp Ban, Threatens 50,000 Jobs</strong></p>
<p>In a late-night vote Wednesday, the Texas House passed SB 3, banning hemp-derived THC products across the state. Championed by Lt. Gov. Dan Patrick, the measure criminalizes products containing any THC or THCA, despite opposition from 50% of voters, per a Texas Politics Project poll. The state's hemp industry, supporting 53,000 jobs and $268 million in tax revenue, now braces for litigation. Advocates are urging a veto.</p>
<p>Meanwhile, HB 46, aimed at expanding Texas' Compassionate Use Program, remains pending in the Senate. It proposes adding qualifying conditions like chronic pain, expanding licensing, and permitting more administration methods—but retains the 1% THC cap and bans flower.</p>
<p><strong>DEA Report Criticizes Legal States, Admits Prohibition Fuels Illicit Trade</strong></p>
<p>In its 2025 National Drug Threat Assessment, the DEA accused cartels of exploiting state-legal cannabis programs. However, the report also acknowledged that demand for illicit cannabis is driven largely by prohibition states—ironically making the case for federal reform.</p>
<p>DEA nominee Terrance Cole, in confirmation hearings, refused to take a position on rescheduling cannabis but called review of the issue a "first priority."</p>
<p><em>Read more on </em><a href="https://www.marijuanamoment.net/dea-blames-legal-marijuana-states-for-inadvertently-aiding-cartels-while-also-admitting-that-prohibition-states-create-illegal-market-opportunities"><em>Marijuana Moment</em></a></p>
<p><strong>Argentina Overhauls REPROCANN Framework</strong></p>
<p>The Ministry of Health issued Resolution 1780/2025, revamping Argentina's cannabis cultivation registry. Key changes include new rules for nonprofit growers, research institutions, and third-party cultivators, plus mandatory training and digital registration for prescribing doctors. While patients can retain current registrations for up to 3 years, others face stricter 1-year renewals and enhanced oversight.</p>
<p><em>Full breakdown via </em><a href="https://elplanteo.com/reprocann-cambios-2025"><em>El Planteo</em></a></p>
<h3 class="wp-block-heading">Corporate &amp; M&amp;A</h3>
<p><strong>Blüm Holdings to Deepen Stake in Cookies</strong></p>
<p><strong>Blüm Holdings, Inc.</strong> (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/BLMH#OTCQB">BLMH</a>) signed a binding term sheet to acquire 100% of a holding company with an indirect equity stake in Cookies Creative Consulting &amp; Promotions, Inc. The transaction—worth roughly $562,500—could amplify Blüm's presence alongside one of cannabis's most recognized brands.</p>
<p><strong>Village Farms Spins Off Fresh Produce Arm to Focus on Cannabis</strong></p>
<p><strong>Village Farms</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) will transfer key greenhouse and distribution assets to a new private joint venture with Sweat Equities, dubbed Vanguard Food LP. The move unlocks $40 million in cash and refocuses the company's strategy on international cannabis.</p>
<h3 class="wp-block-heading">Global Markets</h3>
<p><strong>Canada: Industry Pushes for Excise Tax Reform</strong></p>
<p>Deloitte's 2025 report confirmed that Canada's cannabis excise tax model is crushing legal operators. The Cannabis Council of Canada renewed calls to replace the $1/gram floor with a 10% ad valorem tax, noting that current rules are outdated and misaligned with market prices.</p>
<p><strong>GrowerIQ to Represent Canada on Thailand Trade Mission</strong></p>
<p>Toronto-based GrowerIQ was selected by Global Affairs Canada to join a trade mission to Thailand, becoming the only cannabis company in the delegation. Thailand's market, legal since 2022, is expected to grow at a 33% CAGR over five years.</p>
<p><strong>Tilray Launches &#8216;Good Supply&#8217; in Germany</strong></p>
<p><strong>Tilray Brands</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) expanded its European medical cannabis footprint with Good Supply's launch in Germany. Strains include Snow Leopard, Purple Octane and Lemon Haze Gelato. Products will be available via prescription at German pharmacies.</p>
<p><em>Read more on </em><a href="https://www.benzinga.com/markets/cannabis/25/05/45573520/after-bankruptcy-and-a-lost-home-this-cannabis-team-rebuilt-from-the-ground-up-the-real-story-of-blimburn-seeds"><em>Benzinga</em></a></p>
<p><strong>Curaleaf and TILT Secure EU Certification for Medical Inhaler</strong></p>
<p><strong>Curaleaf International</strong>, a subsidiary of <strong>Curaleaf</strong> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) and <strong>TILT Holdings</strong> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TLLTF#OTC">TLLTF</a>) announced EU Class IIa certification for their new handheld medical cannabis inhaler. The approval unlocks opportunities across the EU, UK, Canada, and Australasia.</p>
<h3 class="wp-block-heading">Financials</h3>
<p><strong>Planet 13 Reports Q1 Revenue of $28M</strong></p>
<p><strong>Planet 13 Holdings</strong> (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/PLNH#OTCQX">PLNH</a>) posted $28 million in Q1 2025 revenue—a 22.5% YoY increase. Gross margins shrank to 42.8%, while adjusted EBITDA swung to a $2.5 million loss. The company cited pressure on pricing and consumer demand.</p>
<p><strong>Vext Grows Revenue 38%, Hits $3.1M in Operating Cash Flow</strong></p>
<p><strong>Vext Science</strong> (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/VEXTF#OTCQX">VEXTF</a>) reported $11.6 million in Q1 revenue, up 38% YoY. Operating cash flow reached $3.1 million. The company highlighted growth in Ohio and retail resilience in Arizona.</p>
<h3 class="wp-block-heading">Events &amp; Culture</h3>
<p><strong>#InvestInHER Returns to Benzinga Cannabis Capital Conference</strong></p>
<p>Women-led groups like Women Grow, Verdant Strategies and IWC will host mentorship and networking events during the Benzinga Cannabis Capital Conference in Chicago (June 8–10). The #InvestInHER Lounge and scholarship programs aim to boost visibility, funding access, and leadership for women founders.</p>
<p><em>More info </em><a href="http://bzcannabis.com"><em>here</em></a></p>
<h3 class="wp-block-heading">Recommended Reads Of The Week</h3>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/events/25/05/45526151/modelo-got-it-right-cannabis-didnt-says-latina-ceo-who-built-a-multi-state-business-with-10k">Modelo Got It Right, Cannabis Didn&#8217;t, Says Latina CEO Who Built A Multi-State Business With $10K</a></li>
<li><a href="https://www.forbes.com/sites/javierhasse/2025/05/19/how-cannabis-drinks-are-reshaping-booze/">Weed In A Can: How Cannabis Drinks Are Changing The Ritual Of Drinking</a></li>
<li><a href="https://www.forbes.com/sites/javierhasse/2025/05/21/is-cannabis-justice-good-business-ben--jerrys-thinks-so/">Is Cannabis Justice Good Business? Ben &amp; Jerry's Thinks So</a></li>
<li><a href="https://www.benzinga.com/markets/cannabis/25/05/45573520/after-bankruptcy-and-a-lost-home-this-cannabis-team-rebuilt-from-the-ground-up-the-real-story-of-blimburn-seeds">After Bankruptcy And A Lost Home, This Cannabis Team Rebuilt From The Ground Up</a></li>
<li><a href="https://www.greenstate.com/lifestyle/premium-pot-products-newbie/">I gave a weed newbie some premium pot products—here's what he thought</a></li>
</ul>


Cannabis

Government

Politics

BLMH

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

PLNH

TLLTF

TLRY

VEXTF

This Week In Cannabis: DEA Slams Legal Weed, Texas Votes Hemp Ban, Argentina Tightens Medical Rules And More

Easterly Government Properties Acquires 74,549 SF U.S. Department Of Homeland Security Law Enforcement Support Center; Amount Not Disclosed

<p>Another week, another wave of headlines reshaping the <a href="https://www.benzinga.com/cannabis">cannabis</a> world. Maryland legalizes consumption lounges—but no smoking allowed. Hawaii expands medical access but adds a controversial surveillance clause. In Canada, Cannara posts a record quarter, SNDL launches a strategic review and Aurora reinvents its flagship site.</p>
<p>Meanwhile, George Clinton and Wiz Khalifa debut a new pre-roll line, New York quietly approaches $1.5 billion in legal cannabis sales, and THC seltzers make it to morning TV. A new cannabinoid is discovered. Trump's DEA pick dodges questions on rescheduling. And major ETFs rally on the speculation.</p>
<p>From THC cocktails to failed Florida hemp bills, here's everything you need to know.</p>
<h2 class="wp-block-heading">Financials</h2>
<h3 class="wp-block-heading">Cannara Biotech Posts Record Quarter</h3>
<p><strong>Cannara Biotech</strong> (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/LOVFF#OTCQB">LOVFF</a>) reported its sixteenth consecutive quarter of positive adjusted EBITDA, with net revenues rising 35% year-over-year to CA$26.6 million in Q2 2025. The company saw notable market share gains in Quebec, Ontario and Alberta, while gross profit grew 52% to CA$10.8 million. CEO Zohar Krivorot emphasized upcoming grow zone activations and product launches.</p>
<h3 class="wp-block-heading">SNDL Misses Revenue, Launches Strategic Review</h3>
<p><strong>SNDL</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) reported Q1 2025 revenue of CA$204.9 million, missing analyst expectations by nearly CA$38 million. Still, cannabis segments grew by 16.8%, and CEO Zach George highlighted record gross margins and free cash flow gains. SNDL's board has initiated a strategic review, exploring a shift away from major exchanges to increase flexibility with U.S. assets.</p>
<p><a href="https://www.benzinga.com/25/05/45138704">Read more on Benzinga</a></p>
<h3 class="wp-block-heading">Aurora Rebrands Flagship Grow Facility</h3>
<p><strong>Aurora Cannabis</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) announced the completion of a CA$3 million upgrade to its Pemberton, BC site—now renamed <strong>Aurora Alpine</strong>. The facility hit record potency levels (33.7% THC) and doubled its output. It's now central to Aurora's export strategy and GACP-certified for global distribution.</p>
<h3 class="wp-block-heading">POSaBIT Improves Margins, Expands Ecommerce</h3>
<p><strong>POSaBIT</strong> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/POSAF#OTC">POSAF</a>) reported a 19% year-over-year increase in adjusted gross profit and cut OpEx by 35%. Despite a 65% drop in reported revenue, the company says its adjusted financials reflect operational stability. CEO Ryan Hamlin emphasized growth in Washington and success of the new ecommerce platform.</p>
<h3 class="wp-block-heading">Red White &amp; Bloom Restructures CA$145M In Debt</h3>
<p><strong>Red White &amp; Bloom</strong> (CSE:<a class="ticker" href="https://www.benzinga.com/stock/RWB#CSE">RWB</a>) eliminated conversion rights on CA$145M in debt—avoiding 198 million potential shares—and extended maturity dates through 2026–27. All payments are deferred, with CA$2.5 million in annual interest savings. A Management Cease Trade Order is in effect while the company completes its audit.</p>
<h2 class="wp-block-heading">Product Launches</h2>
<h3 class="wp-block-heading">George Clinton And Wiz Khalifa Drop &#8216;THE FUNK&#8217;</h3>
<p><strong>Planet 13</strong> (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/PLNHF#OTCQX">PLNHF</a>) hosted the exclusive launch of <strong>THE FUNK</strong>, an infused pre-roll line from George Clinton and Wiz Khalifa. Sold under the Khalifa Kush umbrella, the launch featured a fan meet-and-greet in Las Vegas and promises more drops soon.</p>
<p><a href="https://www.benzinga.com/markets/cannabis/25/04/45074846">Read more on Benzinga</a></p>
<h3 class="wp-block-heading">Shift Naturals Ups the Dose</h3>
<p><strong>Shift Naturals</strong> released a THC cocktail variety pack with 4mg THC and 12mg CBD per can, a step up from its original DownShift product. The drinks come in Margarita, Paloma and Ginger Sour, and aim to offer an alcohol-free, mellow experience rooted in "plant-based science."</p>
<h2 class="wp-block-heading">Regulatory News</h2>
<h3 class="wp-block-heading">Maryland Legalizes Cannabis Lounges—Sort Of</h3>
<p>Governor Wes Moore signed SB 215, allowing cannabis lounges in Maryland—so long as there's no smoking. Instead, edibles and 5mg THC drinks (made by licensed operators) will be permitted on-site.</p>
<p><a href="https://www.marijuanamoment.net/maryland-governor-signs-bill-legalizing-smokeless-marijuana-consumption-lounges/">Continue reading on Marijuana Moment</a></p>
<h3 class="wp-block-heading">Hawaii Expands Medical Access, Raises Privacy Flags</h3>
<p>Hawaii lawmakers passed HB 302, allowing doctors to recommend cannabis for any condition they see fit. But advocates raised alarms over new provisions letting the health department access patient records without suspicion or a warrant.</p>
<p><a href="https://www.marijuanamoment.net/hawaii-lawmakers-send-medical-marijuana-reforms-to-governor-including-letting-patients-qualify-for-any-condition-a-doctor-sees-fit/">Continue reading on Marijuana Moment</a></p>
<h3 class="wp-block-heading">Florida Hemp Regulation Bill Dies</h3>
<p>Florida lawmakers failed to reconcile competing hemp bills before the end of session. Rep. Michelle Salzman cited "stylistic differences" between chambers. The issue is expected to return next session.</p>
<p><a href="https://floridapolitics.com/archives/735443-hemp-regulation-bill-snuffed-out/">Read more on Florida Politics</a></p>
<h3 class="wp-block-heading">Cayman Islands Voters Back Decriminalization</h3>
<p>Voters in the Cayman Islands approved a non-binding referendum supporting cannabis decriminalization. Specifics remain undecided, but the measure signals growing regional momentum.</p>
<p><a href="https://www.marijuanamoment.net/cayman-islands-voters-approve-marijuana-decriminalization-referendum/">Continue reading on Marijuana Moment</a></p>
<h2 class="wp-block-heading">Retail Trends</h2>
<h3 class="wp-block-heading">Canada Retail Sales Dip</h3>
<p>StatsCan reported CA$404.7 million in cannabis sales for February 2025, down 7.6% from January but up 0.6% year-over-year. Quebec posted an 18% annual decline, while Ontario rose 9% despite an 8.5% drop from January.</p>
<h3 class="wp-block-heading">Illinois Q1 Sales Fall 6%</h3>
<p>Beacon Securities reported Illinois cannabis sales totaled $482 million in Q1 2025, down 6% from Q4. March sales were $170 million, down 3% from a year ago.</p>
<h3 class="wp-block-heading">New York Approaches $1.5B In Sales</h3>
<p>New York's 2024 market report shows total licensed cannabis sales nearing $1.5 billion. The number of stores tripled to 260 last year, with 81% of retail licenses held by social and economic equity applicants.</p>
<h2 class="wp-block-heading">Politics</h2>
<h3 class="wp-block-heading">Trump's DEA Pick Walks a Tightrope</h3>
<p>Terrance Cole, Trump's nominee for DEA chief, told Congress that rescheduling marijuana would be a top priority. But he declined to support moving cannabis to Schedule III, saying he needed more time to evaluate the science. His prior comments and law enforcement background have left stakeholders split.</p>
<p><a href="https://www.benzinga.com/government/regulations/25/04/45113866/donald-trumps-dea-nominee-reviewing-cannabis-rescheduling-will-be-one-of-my-first-priorities">Read more on Benzinga</a></p>
<p><a href="https://www.cannabisbusinesstimes.com/cannabis-rescheduling/news/15744461/deas-likely-administrator-refuses-to-commit-to-schedule-iii-proposal-for-cannabis">Also, read the contrasting view on Cannabis Business Times</a></p>
<h3 class="wp-block-heading">Matt Gaetz: ‘Reparations' Are Blocking Legalization</h3>
<p>Former congressman Matt Gaetz claimed cannabis reform is stalling because some Democrats tie legalization to reparations. Mason Tvert, his guest, pushed back, pointing to the need for equity after decades of harm. The interview also referenced clemency discussions at the White House and Trump-aligned PAC ads attacking Biden's cannabis record.</p>
<p><a href="https://www.marijuanamoment.net/trumps-first-attorney-general-pick-shares-theory-about-why-marijuana-hasnt-been-federally-legalized-yet/">Read more on Marijuana Moment</a></p>
<h2 class="wp-block-heading">Science</h2>
<h3 class="wp-block-heading">New Cannabinoid Shows Antitumor Potential</h3>
<p>South Korean researchers discovered a new cannabinoid, cannabielsoxa, among 11 compounds studied for anticancer effects. Seven showed strong inhibition of neuroblastoma cells. The discovery adds to growing evidence supporting cannabis in cancer care.</p>
<p><a href="https://www.marijuanamoment.net/researchers-announce-theyve-discovered-a-new-cannabinoid-in-marijuana/">Continue reading on Marijuana Moment</a></p>
<h2 class="wp-block-heading">Market Movers</h2>
<h3 class="wp-block-heading">THC Seltzers Hit National TV</h3>
<p>THC-infused drinks were featured on Good Morning America, highlighting mainstream curiosity about "gardening beverages." The market could hit $4 billion by 2028, per Euromonitor, but regulation remains fragmented across states.</p>
<h3 class="wp-block-heading">Cannabis ETFs Surge</h3>
<p>The MSOS ETF gained nearly 9% this week as optimism grew around DEA rescheduling. Beacon Securities noted investor attention is now focused on Q1 earnings from the Big Five MSOs, expected next week.</p>
<h2 class="wp-block-heading">Industry Impact</h2>
<h3 class="wp-block-heading">MJBiz Forecasts $123.6B Economic Impact</h3>
<p>The MJBiz Factbook projects legal cannabis will contribute $123.6 billion to the U.S. economy in 2025. That includes $35.3 billion in direct sales and $88.3 billion in indirect activity, using a 2.5x multiplier. Despite stalled federal reform, new markets like New York and Ohio are fueling the next wave.</p>
<p><a href="https://mjbizdaily.com/marijuana-industry-will-add-123-6-billion-to-us-economy-this-year/">Read more on MJBizDaily</a></p>
<h2 class="wp-block-heading">Recommended Reads</h2>
<ul>
<li><a href="https://www.forbes.com/sites/javierhasse/2025/05/01/this-one-decision-is-costing-america-up-to-10-billion-a-year/">This One Decision Could Cost America Up To $10 Billion A Year</a> — <em>Forbes</em></li>
<li><a href="https://www.benzinga.com/markets/cannabis/25/04/42034019/wiz-khalifa-talks-smoking-with-snoop-dreaming-of-bob-marley-riding-horses-with-lenny-kravitz-and">Wiz Khalifa on Marley, Snoop and Weed in Germany</a> — <em>Benzinga</em></li>
<li><a href="https://www.forbes.com/sites/javierhasse/2025/04/29/how-a-military-grad-turned-a-coffee-table-disaster-into-a-pink-cannabis-empire/">How A Military Grad Built a Pink Cannabis Empire</a> — <em>Forbes</em></li>
</ul>
<h2 class="wp-block-heading">Until Next Time…</h2>
<p>From policy pivots to celebrity product drops, the cannabis world isn't slowing down. We'll be back next Friday with more headlines, earnings and insight to keep you ahead of the curve.</p>
<p>In the meantime, <a href="https://x.com/JavierHasse">follow me on X</a> for real-time updates.</p>
<p>Stay informed. Stay curious.</p>


Earnings

CSE:RWB

LOVFF

PLNHF

POSAF

SNDL

This Week In Cannabis: Maryland Opens Lounges, DEA Wavers, Retail Trends Shift And More

<p>President <strong>Donald Trump</strong>'s pick to run the <a href="https://www.benzinga.com/topic/drug-enforcement-administration" target="_blank" rel="noreferrer noopener">Drug Enforcement Administration</a> (DEA) is apparently considering a proposal to federally reschedule cannabis. The DEA administrator nominee, <strong><a href="https://www.benzinga.com/markets/cannabis/25/02/43667362/trump-appoints-anti-cannabis-just-say-no-drug-warrior-as-dea-chief">Terrance Cole</a></strong>, says it will be "one of my first priorities" if he's confirmed.</p>
<p>"If confirmed, it'll be one of my first priorities when I arrive at DEA to see where we are in the administrative process," Cole told Sen. <strong>Alex Padilla</strong> (D-CA) during his confirmation hearing before the Senate Judiciary Committee Wednesday. "I'm not familiar exactly where we are, but I know the process has been delayed numerous times—and it's time to move forward." Marijuana Moment first <a href="https://www.marijuanamoment.net/trumps-pick-to-lead-dea-says-marijuana-rescheduling-review-will-be-one-of-my-first-priorities-in-the-job/">reported</a> this story.</p>
<p>Cole, however, declined on several occasions to commit to supporting the proposed rule to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA), which of course is at the core of the reform process.</p>
<p>When pressed on the issue of removing marijuana from its onerous classification as a dangerous drug and moving it to Schedule III, Cole said he needed more time to better understand the situation. "I need to understand more where [agencies] are and look at the science behind it and listen to the experts and really understand where they are in the process."</p>
<p>At the moment, cannabis remains on the <a href="https://www.dea.gov/drug-information/drug-scheduling">DEA's list of Schedule I drugs</a>, along with heroin, LSD and meth and is defined by the agency as a drug "with no currently accepted medical use and a high potential for abuse."</p>
<p>The <a href="https://www.benzinga.com/markets/cannabis/24/05/38880719/biden-announces-monumental-marijuana-rescheduling-doj-to-take-next-steps" target="_blank" rel="noreferrer noopener">marijuana rescheduling process</a> was initiated during the Biden administration but never got off the ground. As such, it remains federally illegal until such time the DEA makes a significant move.</p>
<p>Meanwhile, due to that classification, cannabis companies are subject to various limitations, including an Internal Revenue Code known as&nbsp;<a href="https://www.benzinga.com/topic/irs-code-280e" target="_blank" rel="noreferrer noopener">Section 280E, </a>which disallows all normal business deductions or credits. This applies even to cannabis companies in the 39 U.S. states where marijuana sales are legal.</p>
<p>It&#8217;s also worth noting that the total U.S. economic impact of regulated marijuana sales&nbsp;<a href="https://insights.mjbizdaily.com/factbook-2024/" target="_blank" rel="noreferrer noopener">could top $123.6 billion in 2025</a>, about 9% more than last year, according to a newly released MJBiz Factbook <a href="https://mjbizdaily.com/marijuana-industry-will-add-123-billion-to-us-economy-in-2025/">update</a>.</p>
<p><strong>Now Read:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/25/04/45011379/why-cannabis-stocks-jumped-by-double-digits-and-why-analysts-say-dont-drink-the-kool-aid-in-one-gulp"><strong>Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say &#8216;Don&#8217;t Drink The Kool-Aid In One Gulp&#8217;</strong></a></li>
</ul>
<p><em>Photo: Shutterstock, Eugenio Cuppone via Pixabay</em></p>


Regulations

Donald Trump's DEA Nominee: Reviewing Cannabis Rescheduling Will 'Be One Of My First Priorities'

<p>Easterly Government Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>) raises FY2025 FFO guidance from $1.18-$1.21 to $2.98-$3.03 vs $1.19 analyst estimate..</p>


Guidance

Easterly Government Props Raises FY2025 FFO Guidance from $1.18-$1.21 to $2.98-$3.03 vs $1.19 Est

<p>Easterly Government Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.29 by 151.72 percent. This is a 2.82 percent increase over earnings of $0.71 per share from the same period last year.  The company reported quarterly sales of $78.67 million which missed the analyst consensus estimate of $79.95 million by 1.60 percent.  This is a 8.07 percent increase over sales of $72.80 million the same period last year.</p>


Earnings Beats

Earnings Misses

Easterly Government Props Q1 FFO $0.73 Beats $0.29 Estimate, Sales $78.67M Miss $79.95M Estimate

General

Easterly Government Properties Bags 20-Year Non-Cancelable Lease For A 40,035 Rentable Square Foot Federal District And Federal Magistrate Courthouse In Medford, Oregon

ACGL

AEYE

AMSF

APAM

ARCB

ARCC

ASTE

ASTL

ATRC

BBIO

BBVA

BGFV

BKNG

BRSP

CECO

CHCT

CLVT

CSGP

CVLT

DHIL

ENSG

ENVA

ESRT

ETWO

EXLS

FELE

FFIC

FIBK

FICO

FOUR

FRSH

FRST

FSLR

FYBR

HLMN

HOUS

HRZN

HSBC

HURN

ILPT

INCY

INTZ

JAKK

JBGS

JBLU

KNSA

LFUS

LGIH

Laboratory Corporation Of America Holdings

LOGI

LXFR

Earnings Scheduled For April 29, 2025

<p>The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.</p>
<p>The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.</p>
<p>Here's the latest list of major oversold players in this sector, having an RSI near or below 30.</p>
<h3 class="wp-block-heading"><strong>Easterly Government Properties Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>)</strong></h3>
<ul>
<li>Easterly Government Properties will release its first quarter financial results on April 29. The company's stock fell around 23% over the past month and has a 52-week low of $7.79.</li>
<li><strong>RSI Value:</strong> 23.8</li>
<li><strong>DEA Price Action:</strong> Shares of Easterly Government Properties fell 0.8% to close at $8.30 on Tuesday.</li>
<li>Edge Stock Ratings: 18.64 Momentum score with Value at 59.92.</li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/DEA"><img loading="lazy" decoding="async" width="481" height="188" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061358/image-122.png" alt="" class="wp-image-873898" style="width:384px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061358/image-122.png 481w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061358/image-122-300x117.png 300w" sizes="(max-width: 481px) 100vw, 481px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Summit Hotel Properties Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INN#NYSE">INN</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></h3>
<ul>
<li>Summit Hotel Properties will report financial results for the first quarter on Wednesday, April 30, after the market closes. The company's stock fell around 32% over the past month and<a href="https://www.benzinga.com/quote/INN"> has a 52-week low</a> of $3.57.</li>
<li><strong>RSI Value:</strong> 24.6</li>
<li><strong>INN Price Action:</strong> Shares of Summit Hotel Properties fell 1.8% to close at $3.94 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0416">trend in INN stock</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0416"><img loading="lazy" decoding="async" width="910" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061455/image-123.png" alt="" class="wp-image-873900" style="width:590px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061455/image-123.png 910w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061455/image-123-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061455/image-123-768x711.png 768w" sizes="(max-width: 910px) 100vw, 910px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>LXP Industrial Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXP#NYSE">LXP</a>)</strong></h3>
<ul>
<li>LXP Industrial Trust  will release its first quarter financial results before the opening bell on Thursday, May 1. The company's stock fell around 16% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/LXP">low of $6.85</a>.</li>
<li><strong>RSI Value:</strong> 28.4</li>
<li><strong>LXP Price Action:</strong> Shares of LXP Industrial Trust gained 0.1% to close at $7.69 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0416">LXP shares</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0416"><img loading="lazy" decoding="async" width="877" height="430" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061549/image-124.png" alt="" class="wp-image-873901" style="width:522px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061549/image-124.png 877w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061549/image-124-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16061549/image-124-768x377.png 768w" sizes="(max-width: 877px) 100vw, 877px" /></a></figure></p>
<p>Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a> </p>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/25/04/44811698/jim-cramer-planet-fitness-is-doing-better-than-expected-says-no-to-this-industrial-stock">Jim Cramer: Planet Fitness Is Doing Better Than Expected, Says No To This Industrial Stock</a></strong> </li>
</ul>
<p><em>Photo via Shutterstock</em></p>


Top 3 Real Estate Stocks That May Explode In Q2

WIIM

APLE

Shares of REIT stocks are trading lower amid an overall market reversal. The sector may also be down amid a rise in the 30-year Treasury yield.

CORRECTION: Easterly Government Properties Reduces Quarterly Dividend From $0.265 To $0.180

Easterly Government Properties Says After Giving Effect To The Reverse Stock Split And The Payment Of The Company's Quarterly Cash Dividend, The Company Reaffirms Its 2025 Earnings Outlook

Stock Split

Easterly Government Properties Approved 1-For-25 Reverse Stock Split

<p>During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.</p>
<p>Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.</p>
<p>Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.</p>
<h3 class="wp-block-heading"><strong>Easterly Government Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield:</strong> 11.52%</li>
<li><strong>RBC Capital </strong>analyst Michael Carroll maintained an Underperform rating and cut the price target from $12 to $11 on March 10, 2025. This analyst has an accuracy rate of 64%.</li>
<li><strong>Truist Securities </strong>analyst Michael Lewis maintained a Hold rating and slashed the price target from $14 to $13 on Dec. 6, 2024. This analyst has an accuracy rate of 69%.</li>
<li><strong>Recent News:</strong> On March 25, Easterly Government Properties issued $125 million in senior unsecured notes.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409">latest DEA news</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409"><img loading="lazy" decoding="async" width="907" height="803" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042004/image-47.png" alt="" class="wp-image-863275" style="width:479px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042004/image-47.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042004/image-47-300x266.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042004/image-47-768x680.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Park Hotels &amp; Resorts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PK#NYSE">PK</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield:</strong> 11.30%</li>
<li><strong>Truist Securities </strong>analyst Patrick Scholes maintained a Buy rating and slashed the price target from $18 to $16 on March 21, 2025. This analyst has an accuracy rate of 62%.</li>
<li><strong>UBS </strong>analyst Robin Farley maintained a Neutral rating and cut the price target from $15 to $13 on Feb. 3, 2025. This analyst has an accuracy rate of 77%.</li>
<li><strong>Recent News:</strong> Park Hotels &amp; Resorts will release its financial results for the first quarter before the stock market opens on Monday, May 5.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409">latest PK news</a> </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409"><img loading="lazy" decoding="async" width="912" height="827" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042041/image-48.png" alt="" class="wp-image-863276" style="width:516px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042041/image-48.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042041/image-48-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042041/image-48-768x696.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>OUTFRONT Media Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUT#NYSE">OUT</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield: </strong>9.05%</li>
<li><strong>Morgan Stanley </strong>analyst Benjamin Swinburne maintained an Equal-Weight rating and raised the price target from $17.51 to $18.54 on Dec. 18, 2024. This analyst has an accuracy rate of 76%.</li>
<li><strong>TD Cowen </strong>analyst Lance Vitanza initiated coverage on the stock with a Hold rating and a price target of $16.48 on July 16, 2024. This analyst has an accuracy rate of 73%.</li>
<li><strong>Recent News: </strong>On Feb. 25, Outfront Media reported fourth-quarter financial results and beat its EPS and revenue estimates.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest OUT <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409">news </a></li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409"><img loading="lazy" decoding="async" width="915" height="817" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042117/image-49.png" alt="" class="wp-image-863277" style="width:547px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042117/image-49.png 915w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042117/image-49-300x268.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09042117/image-49-768x686.png 768w" sizes="(max-width: 915px) 100vw, 915px" /></a></figure></p>
<p><figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><br />
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
<p></p></figure></p>
<p><strong>Read More: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/25/04/44684755/top-3-industrials-stocks-you-may-want-to-dump-this-month">Top 3 Industrials Stocks You May Want To Dump This Month</a></strong> </li>
</ul>
<p><em>Photo via Shutterstock</em></p>


Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 9% Dividend Yields

<p>The <strong>U.S. <a href="https://www.benzinga.com/topic/drug-enforcement-administration">Drug Enforcement Administration</a> (DEA) </strong>is trying to be cool again. And by "cool," we mean desperately attempting to curb the inevitable: weed is mainstream, legal in much of the U.S. and enjoying a global glow-up. But instead of rolling with the times, the DEA has teamed up with anti-cannabis nonprofit <strong>Johnny's Ambassadors</strong> to recruit young people for a TikTok—sorry, Instagram—campaign against <a href="https://www.benzinga.com/topic/thc">THC</a>. As <a href="https://www.marijuanamoment.net/dea-promotes-anti-420-day-contest-for-young-people-to-flood-instagram-with-marijuana-warnings/">reported</a> by Marijuana Moment&#8217;s <strong>Kyle Jaeger</strong>, the plan is to pay kids to make videos bashing weed because nothing says authenticity like a government-funded hashtag campaign.</p>
<h3 class="wp-block-heading">Paying Teens To Say No To Weed</h3>
<p>For its latest "Just Say No" remix, the DEA is <a href="https://content.govdelivery.com/accounts/USDOJDEAJTT/bulletins/3d86b96">dangling cash</a> in front of students to get them to post anti-THC videos ahead of April 20—aka 4/20, aka Christmas for stoners. The going rate? A whopping $25 for a solo rant, $35 for a group effort and a mighty $50 for a professionally shot skit (with adult supervision, of course). The goal? To "flood" Instagram with anti-cannabis content, telling young people that weed is bad.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/markets/cannabis/25/03/44476373/are-marijuana-taxes-too-high-they-already-beat-alcohol-and-tobacco-and-theyre-about-to-get-worse">Are Marijuana Taxes Too High? They Already Beat Alcohol And Tobacco And They&#8217;re About To Get Worse</a></strong></p>
<p>Johnny's Ambassadors, the group leading this crusade, wants videos explaining how THC supposedly tanks athletic performance, busting "myths" about cannabis, or sharing sob stories about how pot ruined someone's life. But let's be clear: no cussing, no laughing and absolutely no pretending to smoke not even as a joke.</p>
<h3 class="wp-block-heading">The Timing Is…Suspicious</h3>
<p>Now, let's talk about why this is weird. The DEA is in the middle of potentially rescheduling cannabis, a move that would mark the biggest federal shift on marijuana in decades. So why, in the middle of this seismic policy moment, is the agency pushing what feels like a D.A.R.E. campaign with better lighting?</p>
<p>Johnny's Ambassadors has a deeply personal backstory. The group was founded by parents of a teenager who died by suicide after consuming high-potency cannabis concentrates. Their grief is real, but their messaging leans hard into old-school fear tactics, avoiding the kind of harm reduction strategies that have proven effective elsewhere.</p>
<h3 class="wp-block-heading">The DEA's Cringe-Worthy Track Record</h3>
<p>This isn't even the DEA's first time fumbling the "relatable youth messaging" thing. In 2023, the agency suggested teens could get a "natural high" by becoming famous on Instagram or staring at puppies at a pet store. That really happened. And who could forget the infamous <a href="https://elplanteo.com/emojis-drogas-vender-dea/">guide on decoding "drug emojis,"</a> which had all the accuracy of a Boomer trying to interpret Gen Z slang?</p>
<p>Now, we've got the DEA awkwardly cosigning a campaign that's paying kids to be anti-weed influencers—while the rest of the country moves on, puffing away legally.</p>
<h3 class="wp-block-heading"><strong>Can The DEA Stop The Inevitable?</strong></h3>
<p>The cannabis industry isn't slowing down. The DEA can fund as many Instagram campaigns as it wants, but the reality is clear: legal weed is a juggernaut, markets are expanding and public opinion is overwhelmingly pro-cannabis. The real question is, will this campaign actually get traction? Or will it be another entry in the DEA's Greatest Hits of Embarrassing Youth Outreach?</p>
<p>Either way, mark your calendars: April 20 is coming, and no Instagram video will stop the smoke from rolling in.</p>
<p><strong>Now Read:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/25/03/44492783/420-in-san-francisco-heres-why-sf-space-walk-should-be-on-your-radar"><strong>4/20 In San Francisco? Here&#8217;s Why SF Space Walk Should Be On Your Radar</strong></a></li>
</ul>
<p><em>Lead image via Shutterstock</em></p>


The DEA Wants Teens To Become Anti-Weed Influencers For $25 A Pop

<p>Jefferies  analyst Peter Abramowitz   initiates coverage on Easterly Government Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>) with a Buy rating and announces Price Target of $13.</p>


Initiation

Jefferies Initiates Coverage On Easterly Government Props with Buy Rating, Announces Price Target of $13

<p>During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.</p>
<p>Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.</p>
<p>Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.</p>
<h3 class="wp-block-heading"><strong>Easterly Government Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield:</strong> 10.33%</li>
<li><strong>RBC Capital </strong>analyst Michael Carroll maintained an Underperform rating and cut the price target from $12 to $11 on March 10, 2025. This analyst has an accuracy rate of 65%.</li>
<li><strong>Truist Securities </strong>analyst Michael Lewis maintained a Hold rating and lowered the price target from $14 to $13 on Dec. 6, 2024. This analyst has an accuracy rate of 70%.</li>
<li><strong>Recent News:</strong> On Feb. 25, Easterly Government Props posted fourth-quarter FFO of 29 cents, in-line with estimates.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest DEA <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">news</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="905" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033554/image-119.png" alt="" class="wp-image-824364" style="width:475px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033554/image-119.png 905w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033554/image-119-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033554/image-119-768x710.png 768w" sizes="(max-width: 905px) 100vw, 905px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Park Hotels &amp; Resorts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PK#NYSE">PK</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield:</strong> 9.17%</li>
<li><strong>UBS </strong>analyst Robin Farley maintained a Neutral rating and cut the price target from $15 to $13 on Feb. 3, 2025. This analyst has an accuracy rate of 80%.</li>
<li><strong>Wolfe Research </strong>analyst Keegan Carl downgraded the stock from Outperform to Peer Perform on Sept. 26, 2024. This analyst has an accuracy rate of 66%.</li>
<li><strong>Recent News:</strong> On Feb. 19, Park Hotels &amp; Resorts posted better-than-expected quarterly revenue.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">latest PK news</a> </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="900" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033629/image-120.png" alt="" class="wp-image-824366" style="width:492px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033629/image-120.png 900w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033629/image-120-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033629/image-120-768x714.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Healthcare Realty Trust Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield: </strong>7.60%</li>
<li><strong>Wedbush </strong>analyst Richard Anderson downgraded the stock from Neutral to Underperform and cut the price target from $18 to $16 on Jan. 2, 2025. This analyst has an accuracy rate of 68%.</li>
<li><strong>Wells Fargo </strong>analyst James Feldman assumed an Underweight rating and raised the price target from $16 to $17 on Oct. 1, 2024. This analyst has an accuracy rate of 61%.</li>
<li><strong>Recent News: </strong>On Feb. 19, Healthcare Realty Trust reported quarterly earnings of 40 cents per share.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">HR news</a> </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="912" height="845" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033711/image-121.png" alt="" class="wp-image-824369" style="width:567px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033711/image-121.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033711/image-121-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/14033711/image-121-768x712.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure></p>
<p><figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><br />
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
<p></p></figure></p>
<p><strong>Read More:</strong></p>
<ul>
<li><strong> <a href="https://www.benzinga.com/markets/25/03/44300558/jim-cramer-arthur-j-gallagher-is-solid-this-industrial-company-is-fantastic">Jim Cramer: Arthur J. Gallagher Is &#8216;Solid,&#8217; This Industrial Company Is &#8216;Fantastic&#8217;</a></strong></li>
</ul>


Wall Street's Most Accurate Analysts Spotlight On 3 Real Estate Stocks Delivering High-Dividend Yields

<p>RBC Capital  analyst Michael Carroll   maintains Easterly Government Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>) with a Underperform and lowers the price target from $12 to $11.</p>


RBC Capital Maintains Underperform on Easterly Government Props, Lowers Price Target to $11

<p>Markets fell broadly Tuesday with the S&amp;P 500 trading at five-week lows and the Nasdaq extending its three-day losing streak. The Dow Jones managed to recover midday while Wall Street digested a weaker-than-anticipated consumer confidence survey from the Conference Board, adding to concerns over the health of the U.S. <a href="https://www.benzinga.com/news/25/02/43949339/consumer-confidence-plummets-in-february-sharp-decline-marks-third-consecutive-monthly-drop">consumer and job market. </a></p>
<p>Escalating trade concerns are also weighing on markets after President <strong>Donald Trump</strong> announced on Monday that tariffs on imports from Canada and Mexico "will go forward" and Bloomberg reported the White House is preparing tighter restrictions on semiconductor exports to China.&nbsp;</p>
<p><strong>NVIDIA Corp.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) led the Nasdaq lower as investors anticipate the company's earnings release on Wednesday and shares of <strong>Tesla, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell after the EV giant saw a sharp decline in European sales. </p>
<p><strong>Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43949800/tesla-competes-against-chinese-rivals-with-one-hand-tied-behind-its-back-analyst">Tesla Competes Against Chinese Rivals &#8216;With One Hand Tied Behind Its Back&#8217;: Analyst</a></strong></p>
<p><strong>Bitcoin </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell below $88,000, its lowest since November 2024, as concerns over a slowing U.S. economy and Trump's trade policies<a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43945957/liquidity-is-disappearing-bitcoins-downturn-spells-doom-for-altcoins-analyst-warns"> weighed on </a>crypto markets. </p>
<p>The yield on the U.S. 10-year Treasury note fell about 9 bps to 4.32% as investors flocked toward safe-haven assets.  The <strong>iShares 20+ Year Treasury Bond ETF</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) rose 1.49%. </p>
<h1 class="wp-block-heading"><strong>Tuesday's Performance In Major U.S. Indices, ETFs</strong></h1>
<p><figure class="wp-block-table"><br />
<table>
<tbody>
<tr>
<td><strong>Major Indices</strong></td>
<td><strong>Price</strong></td>
<td><strong>1 day % chg.</strong></td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,072.35</td>
<td>-1.12%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,957.58</td>
<td>-0.43%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>43,597.47</td>
<td>0.31%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,165.29</td>
<td>-0.59%</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>According to Benzinga Pro data:</strong></p>
<ul>
<li>The <strong>SPDR S&amp;P 500 ETF Trust</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was down 0.48% to $594.36.</li>
<li>The<strong> SPDR Dow Jones Industrial Average</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) climbed 0.28% at $435.76.</li>
<li>The tech-heavy <strong>Invesco QQQ Trust Series</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) slid 0.98% to $514.78.</li>
<li>The<strong> iShares Russell 2000 ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) eased down 0.38% to $215.41.</li>
<li>The <strong>Consumer Discretionary Select Sector SPDR Fund</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) was down 0.8% to $215.84.</li>
<li>The <strong>Energy Select Sector SPDR Fund</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) fell 1.53% to $89.56.</li>
</ul>
<h1 class="wp-block-heading"><strong>Tuesday's Stock Movers </strong></h1>
<p><strong>Hims &amp; Hers Health, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares plunged after<a href="https://www.benzinga.com/general/health-care/25/02/43926641/hims-hers-health-stock-drops-after-q4-report-eps-in-line-revenues-beat"> the company reported</a> a decline gross margins in the fourth-quarter added to concern over the end of the FDA-declared shortage of semaglutide.</p>
<p>Stocks reacting to company earnings reports included:&nbsp;</p>
<ul>
<li><strong>Krispy Kreme, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNUT#NASDAQ">DNUT</a>) </li>
<li><strong>Chegg, Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) </li>
<li><strong>Home Depot, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) </li>
<li><strong>Easterly Government Properties, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>) </li>
<li><strong>Keurig Dr Pepper Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>) </li>
<li><strong>Trip.com Group Limited</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) </li>
</ul>
<p>Companies reporting after Tuesday's closing bell include:&nbsp;</p>
<ul>
<li><strong>Lucid Group, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) </li>
<li><strong>AMC Entertainment, Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) </li>
<li><strong>Workday, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) </li>
<li><strong>Maplebear (Instacart) Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) </li>
<li><strong>First Solar, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) </li>
<li><strong>Caesars Entertainment, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>) </li>
<li><strong>Coupang, Inc.  </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPNG#NYSE">CPNG</a>) </li>
<li><strong>Intuit Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) </li>
<li><strong>CAVA Group, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) </li>
</ul>
<p><strong>Read Next:</strong><a href="https://www.benzinga.com/news/earnings/25/02/43945252/lucid-q4-earnings-preview-production-deliveries-margins-on-watch"><strong> </strong></a></p>
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43945252/lucid-q4-earnings-preview-production-deliveries-margins-on-watch"><strong>Lucid Q4 Earnings Preview: Production, Deliveries, Margins On Watch</strong></a></li>
</ul>
<p><em>Image: Shutterstock </em></p>


Equities

Large Cap

Market Summary

Sector ETFs

Broad U.S. Equity ETFs

Treasuries

Movers

Tech

ETFs

$BTC

CART

CAVA

CHGG

CPNG

SPDR Dow Jones Industrial Average ETF Trust

DNUT

Hims & Hers Health, Inc. Class A Common Stock

HIMS

INTU

LCID

NVDA

TCOM

iShares Trust Barclays 20+ Year Treasury Bond Fund

TSLA

WDAY

Select Sector SPDR-Consumer Discretionary

Bitcoin Plunges As Consumer Confidence Falls: What's Driving Markets Tuesday?

Press Releases

Easterly Government Properties Issues $125 Million in Senior Unsecured Notes

Easterly Government Properties Announces Reduction of Quarterly Dividend, Reverse Stock Split to Enhance Long-Term Growth Strategy and Reaffirms 2025 Guidance

Easterly Government Properties Schedules First Quarter 2025 Earnings Release and Conference Call

Easterly Government Properties Completes Reverse Stock Split

Easterly Government Properties Acquires 289,873 SF Facility Primarily Leased to AA+ Rated District of Columbia Government

Easterly Government Properties Awarded Lease to Develop 40,035 RSF Federal Courthouse in Medford, Oregon

Easterly Government Properties Reports First Quarter 2025 Results

Easterly Government Properties to Participate in Wells Fargo 28th Annual Real Estate Securities Conference

Easterly Government Properties Acquires 74,549 SF U.S. Department of Homeland Security Law Enforcement Support Center, 100% Leased, and Located Near Burlington, Vermont

Easterly Government Properties to Participate at Nareit's REITweek 2025 Investor Conference

Comments

Easterly Government Props

Notizie

Ultime notizie per Easterly Government Props (NYSE:DEA) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO